X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6872) 6872
Newsletter (39) 39
Magazine Article (20) 20
Book Chapter (10) 10
Conference Proceeding (8) 8
Book / eBook (4) 4
Dissertation (2) 2
Publication (2) 2
Reference (1) 1
Transcript (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (5091) 5091
humans (4987) 4987
life sciences & biomedicine (4761) 4761
female (3022) 3022
nitriles - therapeutic use (2946) 2946
male (2290) 2290
nitriles (2136) 2136
animals (1841) 1841
middle aged (1661) 1661
triazoles - therapeutic use (1637) 1637
aged (1368) 1368
nitriles - pharmacology (1367) 1367
breast neoplasms - drug therapy (1353) 1353
oncology (1307) 1307
pharmacology & pharmacy (1087) 1087
adult (1047) 1047
treatment outcome (975) 975
nitriles - administration & dosage (896) 896
antineoplastic agents, hormonal - therapeutic use (832) 832
analysis (801) 801
breast cancer (769) 769
aromatase inhibitors - therapeutic use (711) 711
chemistry (709) 709
nitriles - adverse effects (700) 700
rats (681) 681
physical sciences (641) 641
antineoplastic agents - therapeutic use (640) 640
mice (612) 612
tamoxifen - therapeutic use (579) 579
cancer (569) 569
care and treatment (555) 555
aged, 80 and over (525) 525
breast neoplasms - pathology (515) 515
letrozole (500) 500
postmenopause (500) 500
triazoles - administration & dosage (500) 500
aromatase inhibitors (478) 478
medicine & public health (478) 478
prostatic neoplasms - drug therapy (468) 468
biochemistry & molecular biology (462) 462
antineoplastic combined chemotherapy protocols - therapeutic use (457) 457
anilides - therapeutic use (445) 445
time factors (431) 431
research (430) 430
abridged index medicus (412) 412
adamantane - analogs & derivatives (407) 407
chemistry, analytical (406) 406
anastrozole (400) 400
cell line, tumor (394) 394
butadienes - pharmacology (392) 392
triazoles - adverse effects (391) 391
androgen antagonists - therapeutic use (386) 386
health aspects (380) 380
chemotherapy, adjuvant (379) 379
drug therapy, combination (368) 368
double-blind method (366) 366
dose-response relationship, drug (361) 361
mass spectrometry (354) 354
endocrinology & metabolism (350) 350
drug therapy (345) 345
prostate cancer (335) 335
neurosciences & neurology (334) 334
enzyme inhibitors - therapeutic use (315) 315
methods (314) 314
diabetes mellitus, type 2 - drug therapy (311) 311
tosyl compounds (303) 303
adamantane - therapeutic use (300) 300
pyrrolidines - therapeutic use (299) 299
tamoxifen (290) 290
disease-free survival (289) 289
research article (287) 287
liquid chromatography (284) 284
obstetrics & gynecology (284) 284
enzyme inhibitors - pharmacology (278) 278
clinical trials as topic (275) 275
nitriles - chemistry (269) 269
breast neoplasms - metabolism (267) 267
randomized controlled trials as topic (266) 266
proteins (257) 257
retrospective studies (254) 254
triazoles - pharmacology (254) 254
prospective studies (248) 248
toxicology (248) 248
clinical trials (246) 246
reproducibility of results (246) 246
apoptosis (245) 245
cell biology (239) 239
hypoglycemic agents - therapeutic use (238) 238
medicine (237) 237
nitriles - pharmacokinetics (236) 236
urology & nephrology (236) 236
internal medicine (235) 235
biochemical research methods (234) 234
rats, sprague-dawley (234) 234
surgery (233) 233
neurosciences (232) 232
pharmacology/toxicology (231) 231
follow-up studies (230) 230
prostatic neoplasms - pathology (226) 226
apoptosis - drug effects (224) 224
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6594) 6594
Japanese (106) 106
German (104) 104
French (53) 53
Spanish (47) 47
Russian (42) 42
Chinese (35) 35
Italian (33) 33
Portuguese (15) 15
Hungarian (12) 12
Czech (8) 8
Norwegian (4) 4
Dutch (3) 3
Finnish (2) 2
Polish (2) 2
Swedish (2) 2
Turkish (2) 2
Croatian (1) 1
Danish (1) 1
Hebrew (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The lancet oncology, ISSN 1470-2045, 2011, Volume 12, Issue 5, pp. 496 - 503
Summary In March, 2010, a group of breast cancer experts met to develop a consensus statement on breast cancer prevention, with a focus on medical and therapeutic interventions... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Thiophenes - therapeutic use | Metformin - therapeutic use | Raloxifene Hydrochloride - therapeutic use | Humans | Selective Estrogen Receptor Modulators - adverse effects | Tetrahydronaphthalenes - therapeutic use | Pyrrolidines - therapeutic use | Antineoplastic Agents, Hormonal - adverse effects | Aromatase Inhibitors - adverse effects | Estrogen Receptor Modulators - therapeutic use | Retinoids - therapeutic use | Selective Estrogen Receptor Modulators - therapeutic use | Antineoplastic Agents, Hormonal - therapeutic use | Diphosphonates - therapeutic use | Female | Aromatase Inhibitors - therapeutic use | Estrogen Receptor Modulators - adverse effects | Anticarcinogenic Agents - therapeutic use | Triazoles - therapeutic use | Premenopause | Anastrozole | Consensus Development Conferences as Topic | Breast Neoplasms - prevention & control | Fenretinide - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Piperidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Tamoxifen - therapeutic use | Androstadienes - therapeutic use | Expert Testimony | Norpregnenes - therapeutic use | Nitriles - therapeutic use | COX-2 inhibitors | Care and treatment | Aspirin | Oncology, Experimental | Menopause | Phosphonates | Breast cancer | Retinoids | Research | Tamoxifen | Prevention | Analysis | Health aspects | Cancer | Index Medicus
Journal Article
Best Practice & Research: Clinical Endocrinology & Metabolism, ISSN 1521-690X, 2007, Volume 21, Issue 4, pp. 517 - 533
Inhibition of dipeptidyl peptidase 4 (DPP-4) is a novel treatment for type-2 diabetes. DPP-4 inhibition prevents the inactivation of glucagon-like peptide 1... 
Endocrinology & Metabolism | treatment | dipeptidyl peptidase 4 | sitagliptin | type-2 diabetes | vildagliptin | glucagon-like peptide-1 | Life Sciences & Biomedicine | Science & Technology | Triazoles - adverse effects | Metformin - therapeutic use | Humans | Body Weight - drug effects | Pyrrolidines - adverse effects | Substrate Specificity | Glucagon-Like Peptide 1 - physiology | Pyrazines - therapeutic use | Pyrrolidines - therapeutic use | Thiazolidinediones - therapeutic use | Adamantane - therapeutic use | Sitagliptin Phosphate | Drug Therapy, Combination | Hypoglycemia - chemically induced | Protease Inhibitors - therapeutic use | Insulin Secretion | Adamantane - adverse effects | Adamantane - analogs & derivatives | Triazoles - therapeutic use | Hypoglycemic Agents - therapeutic use | Pioglitazone | Insulin - metabolism | Animals | Dipeptidyl-Peptidase IV Inhibitors | Lipid Metabolism - drug effects | Pyrazines - adverse effects | Glucagon - metabolism | Vildagliptin | Glucagon-Like Peptide 1 - antagonists & inhibitors | Diabetes Mellitus, Type 2 - drug therapy | Nitriles - adverse effects | Insulin - therapeutic use | Nitriles - therapeutic use | Index Medicus | Clinical Medicine | Other Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Adamantane/adverse effects Adamantane/analogs & derivatives Adamantane/therapeutic use Animals Antigens | Annan klinisk medicin | Combination Glucagon/secretion Glucagon-Like Peptide 1/antagonists & inhibitors Glucagon-Like Peptide 1/physiology Humans Hypoglycemia/chemically induced Hypoglycemic Agents/therapeutic use Insulin/secretion Insulin/therapeutic use Lipid Metabolism/drug effects Metformin/therapeutic use Nitriles/adverse effects Nitriles/therapeutic use Protease Inhibitors/therapeutic use Pyrazines/adverse effects Pyrazines/therapeutic use Pyrrolidines/adverse effects Pyrrolidines/therapeutic use Substrate Specificity Thiazolidinediones/therapeutic use Triazoles/adverse effects Triazoles/therapeutic use | Type 2/drug therapy Drug Therapy | Klinisk medicin | CD26/antagonists & inhibitors Body Weight/drug effects Diabetes Mellitus
Journal Article
Journal Article
The New England journal of medicine, ISSN 1533-4406, 02/2009, Volume 360, Issue 7, pp. 679 - 691
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Journal Article